FDA
approval
· 2015-03-20
FDA Approved: FLUTICASONE FUROATE ELLIPTA — Supplemental Application (Prasco Laboratories)
Summary
The FDA approved a supplemental application from Prasco Laboratories for Fluticasone furoate Ellipta, enabling a generic version of the inhaled corticosteroid p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FLUTICASONE FUROATE ELLIPTA (FLUTICASONE FUROATE)